Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% EnrollmentGlobeNewsWire • 10/13/20
Rosen, Globally Respected Investor Counsel, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 10/12/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/12/20
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 10/09/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mesoblast Limited (MESO) InvestorsBusiness Wire • 10/09/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/09/20
Mesoblast Needs A Solution To MSC Scalability Issues - Cynata Therapeutics Has An AnswerSeeking Alpha • 10/09/20
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm – MESOBusiness Wire • 10/09/20
MESO CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Mesoblast Limited (MESO)Business Wire • 10/09/20
MESO CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Mesoblast LimitedBusiness Wire • 10/08/20
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/07/20
Glancy Prongay & Murray LLP Continues Investigation on Behalf of Mesoblast Limited (MESO) InvestorsBusiness Wire • 10/06/20
The Law Offices of Frank R. Cruz Continues Its Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/06/20
The Law Offices of Frank R. Cruz Announces Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/05/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/05/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/03/20
Mesoblast Receives Complete Response Letter From the FDA for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in ChildrenGlobeNewsWire • 10/01/20
Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market BubblesSeeking Alpha • 09/15/20
Mesoblast Wins 2020 Fierce Biotech Innovation of the Year Award for remestemcel-LGlobeNewsWire • 09/15/20
Data Safety Monitoring Board Recommends Continuation of Remestemcel-L Phase 3 Trial in COVID-19 Patients With Acute Respiratory Distress SyndromeGlobeNewsWire • 09/04/20
Mesoblast Limited (MESO) CEO Silviu Itescu on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/27/20
ROSEN, A LEADING NATIONAL LAW FIRM, Continues Investigation of Securities Claims Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact the Firm – MESOBusiness Wire • 08/26/20
